Table 2.
Characteristics of heart disease in two groups of patients with normal and abnormal level of pentraxin-3
| Variables | Normal PTX3 (n = 30) | Abnormal PTX3 (n = 70) | P* |
|---|---|---|---|
| Type of myocardial infarction [n (%)] | 0.050 | ||
| Anterior | 7 (23.3) | 35 (60.0) | |
| Lateral | 4 (12.3) | 1 (1.4) | |
| Inferior | 9 (30.0) | 17 (24.3) | |
| Posterior | 0 (0) | 1 (1.4) | |
| RV Inferior | 8 (26.7) | 13 (18.6) | |
| Inferoposterior | 2 (6.7) | 3 (4.3) | |
| Culprit [n (%)] | 0.030 | ||
| LAD | 7 (23.3) | 38 (54.3) | |
| RCA | 18 (60.0) | 23 (32.9) | |
| LCX | 5 (16.7) | 8 (11.4) | |
| LM | 0 (0) | 1 (1.4) | |
| Pre-dilation [n (%)] | > 0.990 | ||
| Yes | 7 (23.3) | 17 (24.3) | |
| No | 23 (76.7) | 53 (75.7) | |
| Post-dilation [n (%)] | 0.180 | ||
| Yes | 9 (30.0) | 32 (45.7) | |
| No | 21 (70.0) | 38 (54.3) | |
| Thrombectomy [n (%)] | 0.080 | ||
| Yes | 22 (73.3) | 62 (88.6) | |
| No | 8 (26.7) | 8 (11.4) | |
| Killip class [n (%)] | 0.010 | ||
| I | 29 (96.0) | 35 (50.0) | |
| II | 1 (4.0) | 33 (47.1) | |
| III | 0 (0) | 2 (2.9) | |
| Need to repeat PCI [n (%)] | 0.005 | ||
| Yes | 7 (23.3) | 38 (54.3) | |
| No | 23 (76.7) | 32 (45.7) | |
| Left ventricle function [n (%)] | 0.007 | ||
| Normal | 15 (50.0) | 13 (18.6) | |
| Mild dysfunction | 6 (20.0) | 17 (35.7) | |
| Moderate dysfunction | 7 (23.3) | 25 (35.7) | |
| Severe dysfunction | 2 (6.7) | 15 (21.4) | |
| Quantitation of mitral regurgitation [n (%)] | 0.070 | ||
| Without problem | 11 (36.7) | 10 (14.3) | |
| Trivial | 5 (16.7) | 19 (27.1) | |
| Mild | 7 (23.3) | 23 (32.9) | |
| Moderate | 7 (23.3) | 18 (25.7) |
PTX3: Pentraxin-3; RV: Right ventricle; LAD: Left anterior descending; RCA: Right coronary artery; LCX: Left circumflex artery; LM: Left marginal; PCI: percutaneous coronary intervention
*
P-values based on chi-square test except for pre-/post-dilation, thrombectomy and need to repeat PCI which were tested with Fisher's exact test